content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001750050</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
          <com:city>HAMILTON HM11</com:city>
          <com:stateOrCountry>D0</com:stateOrCountry>
          <com:zipCode>HM11</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>441-295-5950</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Sukhatme Mayukh</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza, Floor 5</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>689495</noOfUnitsSold>
        <aggregateMarketValue>8277401.46</aggregateMarketValue>
        <noOfUnitsOutstanding>727949744</noOfUnitsOutstanding>
        <approxSaleDate>12/26/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>12/26/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Option Exercise - Grant date 04/20/2022</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences LTD</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>689495</amountOfSecuritiesAcquired>
        <paymentDate>12/26/2024</paymentDate>
        <natureOfPayment>Wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor, 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>12/23/2024</saleDate>
        <amountOfSecuritiesSold>10796</amountOfSecuritiesSold>
        <grossProceeds>129554.80</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor, 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>12/18/2024</saleDate>
        <amountOfSecuritiesSold>412584</amountOfSecuritiesSold>
        <grossProceeds>4969631.30</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Mayukh Sukhatme c/o Roivant Sciences Ltd.</name>
          <address>
            <com:street1>7th Floor, 50 Broadway,</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Shares</securitiesClassTitle>
        <saleDate>12/24/2024</saleDate>
        <amountOfSecuritiesSold>185946</amountOfSecuritiesSold>
        <grossProceeds>2231699.61</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>12/26/2024</noticeDate>
        <signature>/s/ Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Sukhatme Mayukh</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4757}]
text: 144
  0001750050
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  CLARENDON HOUSE, 2 CHURCH STREET
  HAMILTON HM11
  D0
  HM11
  441-295-5950
  Sukhatme Mayukh
  Officer
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza, Floor 5
  New York
  NY
  10111
  689495
  8277401.46
  727949744
  12/26/2024
  Nasdaq
  Common
  12/26/2024
  Option Exercise - Grant date 04/20/2022
  Roivant Sciences LTD
  N
  689495
  12/26/2024
  Wire
  N
  Mayukh Sukhatme c/o Roivant Sciences Ltd.
  7th Floor, 50 Broadway
  London
  X0
  SW1H 0DB
  Common Shares
  12/23/2024
  10796
  129554.80
  Mayukh Sukhatme c/o Roivant Sciences Ltd.
  7th Floor, 50 Broadway
  London
  X0
  SW1H 0DB
  Common Shares
  12/18/2024
  412584
  4969631.30
  Mayukh Sukhatme c/o Roivant Sciences Ltd.
  7th Floor, 50 Broadway,
  London
  X0
  SW1H 0DB
  Common Shares
  12/24/2024
  185946
  2231699.61
  12/26/2024
  /s/ Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Sukhatme Mayukh